PT97785A - Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina - Google Patents

Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina

Info

Publication number: PT97785A
Authority: PT; Portugal
Prior art keywords: doxazosine; improving treatment; relieving; male; erectile impotence
Prior art date: 1990-05-31

Application number

PT97785A

Other languages

English (en)

Other versions

PT97785B (pt

Inventor

George Mclean Milne

Michael Grant Wyllie

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-31

Filing date

1991-05-29

Publication date

1992-02-28

1991-05-29 Application filed by Pfizer filed Critical Pfizer

1992-02-28 Publication of PT97785A publication Critical patent/PT97785A/pt

1999-01-29 Publication of PT97785B publication Critical patent/PT97785B/pt

Links

RUZYUOTYCVRMRZ-UHFFFAOYSA-N doxazosin Chemical compound C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 RUZYUOTYCVRMRZ-UHFFFAOYSA-N 0.000 title abstract 2
229960001389 doxazosin Drugs 0.000 title abstract 2
230000001856 erectile effect Effects 0.000 abstract 2
201000001881 impotence Diseases 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 abstract 1
229960000528 amlodipine Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Harvester Elements (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Tone Control, Compression And Expansion, Limiting Amplitude (AREA)
Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
Saccharide Compounds (AREA)

PT97785A 1990-05-31 1991-05-29 Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina PT97785B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53149490A	1990-05-31	1990-05-31

Publications (2)

Publication Number	Publication Date
PT97785A true PT97785A (pt)	1992-02-28
PT97785B PT97785B (pt)	1999-01-29

Family

ID=24117862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97785A PT97785B (pt)	1990-05-31	1991-05-29	Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina

Country Status (15)

Country	Link
EP (1)	EP0459666B1 (pt)
JP (1)	JP2522609B2 (pt)
KR (1)	KR930010582B1 (pt)
AT (1)	ATE113839T1 (pt)
AU (1)	AU620282B2 (pt)
CA (1)	CA2043440C (pt)
DE (1)	DE69105040T2 (pt)
DK (1)	DK0459666T3 (pt)
HU (1)	HU208076B (pt)
IE (1)	IE63837B1 (pt)
IL (1)	IL98258A (pt)
MY (1)	MY106528A (pt)
NZ (1)	NZ238339A (pt)
PT (1)	PT97785B (pt)
ZA (1)	ZA914135B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4223800A1 (de) *	1992-07-20	1994-01-27	Cassella Farbwerke Mainkur Ag	Verwendung von 1.2.5-Oxadiazol-2-oxiden zur Behandlung erektiler Dysfunktionen
ES2146249T3 (es) *	1993-02-10	2000-08-01	Bmra Corp Bv	Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.
GB9514465D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
US6143746A (en) *	1994-01-21	2000-11-07	Icos Corporation	Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US6268369B1 (en)	1994-11-16	2001-07-31	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
MX9703518A (es)	1994-11-16	1997-08-30	Synaptic Pharma Corp	Dihidropirimidinas y usos de las mismas.
CA2215307A1 (en) *	1995-03-14	1996-09-19	Vivus, Incorporated	Pharmaceutical compositions and kits for preventing erectile dysfunction
GB9514464D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Medicaments
GB9514473D0 (en) *	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
US6228861B1 (en)	1995-11-16	2001-05-08	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
BR9709230A (pt) *	1996-05-10	1999-08-10	Icos Corp	Composto
US6245773B1 (en)	1996-05-16	2001-06-12	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en)	1996-05-16	2001-01-09	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
EP0849264A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von Doxazosin-Mesylat (Form II)
DE59611417D1 (de) *	1996-12-20	2007-03-29	Heumann Pharma Gmbh & Co	Neue polymorphe Form von Doxazosinmesylat (Form III)
CA2314993A1 (en) *	1997-12-16	1999-06-24	Pfizer Products Inc.	Combination effective for the treatment of impotence
DE19800214A1 (de)	1998-01-06	1999-07-15	Knoll Ag	Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US6268377B1 (en) *	1998-09-28	2001-07-31	Merck & Co., Inc.	Method for treating androgen-related conditions
RU2135195C1 (ru) *	1998-12-17	1999-08-27	Овсюк Валерий Григорьевич	Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации
US6274585B1 (en)	1998-12-23	2001-08-14	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6680323B2 (en)	1998-12-23	2004-01-20	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
GB0008332D0 (en) *	2000-04-04	2000-05-24	Pfizer Ltd	Treament
US6521647B2 (en)	2000-04-04	2003-02-18	Pfizer Inc.	Treatment of renal disorders
EP1280531B1 (en) *	2000-05-12	2007-01-24	Novalar Pharmaceuticals, Inc.	Formulation consisting of phentolamine mesylate and the use thereof
US6720324B2 (en)	2000-07-05	2004-04-13	Synaptic Pharmaceutical Corporation	Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925837A (en) *	1984-09-14	1990-05-15	Synthelabo	Pharmaceutical compositions

1991
- 1991-05-17 EP EP91304430A patent/EP0459666B1/en not_active Expired - Lifetime
- 1991-05-17 DK DK91304430.1T patent/DK0459666T3/da active
- 1991-05-17 AT AT91304430T patent/ATE113839T1/de not_active IP Right Cessation
- 1991-05-17 DE DE69105040T patent/DE69105040T2/de not_active Expired - Fee Related
- 1991-05-24 IL IL9825891A patent/IL98258A/en not_active IP Right Cessation
- 1991-05-29 MY MYPI91000937A patent/MY106528A/en unknown
- 1991-05-29 CA CA002043440A patent/CA2043440C/en not_active Expired - Fee Related
- 1991-05-29 PT PT97785A patent/PT97785B/pt not_active IP Right Cessation
- 1991-05-30 AU AU78077/91A patent/AU620282B2/en not_active Ceased
- 1991-05-30 ZA ZA914135A patent/ZA914135B/xx unknown
- 1991-05-30 IE IE184291A patent/IE63837B1/en not_active IP Right Cessation
- 1991-05-30 NZ NZ238339A patent/NZ238339A/en unknown
- 1991-05-30 KR KR1019910008934A patent/KR930010582B1/ko not_active Expired - Fee Related
- 1991-05-30 HU HU911810A patent/HU208076B/hu not_active IP Right Cessation
- 1991-05-31 JP JP3129562A patent/JP2522609B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR910019618A (ko)	1991-12-19
JPH04235917A (ja)	1992-08-25
CA2043440C (en)	1996-07-30
HU208076B (en)	1993-08-30
KR930010582B1 (ko)	1993-10-30
DE69105040D1 (de)	1994-12-15
IL98258A0 (en)	1992-06-21
MY106528A (en)	1995-06-30
NZ238339A (en)	1997-07-27
ZA914135B (en)	1993-01-27
IE911842A1 (en)	1991-12-04
CA2043440A1 (en)	1991-12-01
PT97785B (pt)	1999-01-29
HUT58520A (en)	1992-03-30
IE63837B1 (en)	1995-06-14
DE69105040T2 (de)	1995-03-23
AU7807791A (en)	1991-12-05
EP0459666B1 (en)	1994-11-09
IL98258A (en)	1996-01-31
EP0459666A3 (en)	1992-06-03
DK0459666T3 (da)	1994-12-05
AU620282B2 (en)	1992-02-13
JP2522609B2 (ja)	1996-08-07
ATE113839T1 (de)	1994-11-15
EP0459666A2 (en)	1991-12-04
HU911810D0 (en)	1991-12-30

Legal Events

Date

Code

Title

Description

1992-02-28

BB1A

Laying open of patent application

Effective date: 19911104

1999-01-29

FG3A

Patent granted, date of granting

Effective date: 19981009

2004-07-30

MM3A

Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040430

Publication	Publication Date	Title
PT97785A (pt)	1992-02-28	Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
DE58906926D1 (de)	1994-03-24	Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
ATE145551T1 (de)	1996-12-15	Brausedosisform sowie verfahren zu deren verabreichung
ZA925562B (en)	1993-04-28	Preparation of fatty acid medicaments
DK164441C (da)	1992-11-09	Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DK0668077T3 (da)	2001-10-08	Produkter, som indeholder G-CSF og TNF-bindende protein
DK0501705T3 (da)	1996-06-03	Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
HU9203288D0 (en)	1992-12-28	Method for producing a compound of medical effect
ATE102830T1 (de)	1994-04-15	Methode zur behandlung des interstitiellen blasenentzuendung.
EP0285856A3 (en)	1990-12-05	Use of dihydroergotamine and its salts in the local treatment of trophic disorders
FI945510A0 (fi)	1994-11-23	Klavulaanihapon diamiinisuolat
EP0362847A3 (en)	1991-03-27	The use of etoperidone for preparing a pharmaceutical composition for treating male impotence
NZ231320A (en)	1992-11-25	Aqueous oral preparations of diclofenac
DK0500953T3 (da)	1997-01-06	Potentiator af antineoplastisk virkning og antineoplastisk middel
IT9086204A0 (it)	1990-05-31	Metodo per la cura dell'impotenza erettiva maschile
ATE91419T1 (de)	1993-07-15	Synergistische kombination zur ophthalmischen verwendung.
DK0711163T3 (da)	2001-11-26	Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
RU93044256A (ru)	1996-06-10	Способ лечения саркоидоза
EP0260790A3 (en)	1992-01-22	Use of pinacidil in the treatment of incontinence
EP0539516A4 (pt)	1994-02-23
EP0482919A3 (en)	1992-08-26	Method and composition for treating leg weakness in fowl by the administration of a non-steroidal anti-inflammatory drug
IT8922778A0 (it)	1989-12-21	Dispositivo per l'applicazione della ionoforesi nella cura dell'impotenza maschile, in particolare per la cura dell'impotenza erettile
MY104932A (en)	1994-07-30	Immunomodulatory azaspiranes
UA10335A (uk)	1996-12-25	Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології